Denali Therapeutics (DNLI) Asset Utilization Ratio (2018 - 2024)
Historic Asset Utilization Ratio for Denali Therapeutics (DNLI) over the last 7 years, with Q2 2024 value amounting to 0.0.
- Denali Therapeutics' Asset Utilization Ratio fell 9967.49% to 0.0 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.0, marking a year-over-year decrease of 9967.49%. This contributed to the annual value of 0.25 for FY2023, which is 23391.26% up from last year.
- Denali Therapeutics' Asset Utilization Ratio amounted to 0.0 in Q2 2024, which was down 9967.49% from 0.22 recorded in Q1 2024.
- In the past 5 years, Denali Therapeutics' Asset Utilization Ratio ranged from a high of 0.28 in Q4 2023 and a low of 0.0 during Q2 2024
- Over the past 5 years, Denali Therapeutics' median Asset Utilization Ratio value was 0.09 (recorded in 2022), while the average stood at 0.14.
- As far as peak fluctuations go, Denali Therapeutics' Asset Utilization Ratio skyrocketed by 75144.76% in 2021, and later plummeted by 9967.49% in 2024.
- Over the past 5 years, Denali Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.25 in 2020, then plummeted by 88.63% to 0.03 in 2021, then surged by 182.83% to 0.08 in 2022, then surged by 242.62% to 0.28 in 2023, then crashed by 99.7% to 0.0 in 2024.
- Its Asset Utilization Ratio stands at 0.0 for Q2 2024, versus 0.22 for Q1 2024 and 0.28 for Q4 2023.